Entresto and Hypoacusis - a phase IV clinical study of FDA data
Summary:
Hypoacusis is found among people who take Entresto, especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Entresto and have Hypoacusis. It is created by eHealthMe based on reports of 91,668 people who have side effects when taking Entresto from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
91,668 people reported to have side effects when taking Entresto.
Among them, 1,843 people (2.01%) have Hypoacusis.
What is Entresto?
Entresto has active ingredients of sacubitril; valsartan. eHealthMe is studying from 91,975 Entresto users for its effectiveness, alternative drugs and more.
What is Hypoacusis?
Hypoacusis (loss of hearing) is found to be associated with 1,858 drugs and 1,134 conditions by eHealthMe.
Number of Entresto and Hypoacusis reports submitted per year:
Time on Entresto when people have Hypoacusis *:
Gender of people who have Hypoacusis when taking Entresto*:
Age of people who have Hypoacusis when taking Entresto *:
Common drugs people take besides Entresto *:
Common side effects people have besides Hypoacusis *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Entresto and have Hypoacusis?
Check whether Hypoacusis is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Hypoacusis and when was it recovered:
Expand to all the drugs that have ingredients of sacubitril; valsartan:
Alternative drugs to, pros and cons of Entresto:
- Entresto (91,975 reports)
Common Entresto side effects:
- Hypotension (abnormally low blood pressure): 12,257 reports
- Breathing difficulty: 8,198 reports
- Dizziness: 7,801 reports
- Fatigue (feeling of tiredness): 7,645 reports
- Death: 7,170 reports
- Cough: 6,173 reports
- Weight decreased: 4,877 reports
- Malaise (a feeling of general discomfort or uneasiness): 4,123 reports
- Weakness: 3,593 reports
Browse all side effects of Entresto:
a b c d e f g h i j k l m n o p q r s t u v w x y zHypoacusis treatments and more:
- Hypoacusis (38,153 reports)
COVID vaccines that are related to Hypoacusis:
- Hypoacusis in Moderna COVID Vaccine
- Hypoacusis in Pfizer BioNTech Covid Vaccine
- Hypoacusis in Johnson and Johnson Covid Vaccine
Common drugs associated with Hypoacusis:
- Lyrica: 2,181 reports
- Xeljanz: 2,003 reports
- Entresto: 1,843 reports
- Aspirin: 1,729 reports
- Prednisone: 1,459 reports
- Enbrel: 1,454 reports
- Lantus: 1,186 reports
- Xeljanz xr: 1,119 reports
- Humalog: 1,095 reports
- Revlimid: 1,016 reports
All the drugs that are associated with Hypoacusis:
- Hypoacusis (1,858 drugs)
Common conditions associated with Hypoacusis:
- Rheumatoid arthritis: 2,304 reports
- Multiple sclerosis: 1,776 reports
- High blood pressure: 1,403 reports
- Type 2 diabetes: 1,369 reports
- Multiple myeloma: 1,184 reports
- Diabetes: 1,156 reports
- High blood cholesterol: 1,119 reports
All the conditions that are associated with Hypoacusis:
- Hypoacusis (1,134 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on sacubitril; valsartan (the active ingredients of Entresto) and Entresto (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Colecalciferol and Bladder Disorder - 2 seconds ago
- Evista and Counterfeit Drug Administered - 3 seconds ago
- Prometrium and Iron Deficiency Anaemia - 6 seconds ago
- Calciparine and Proteinuria Aggravated - 6 seconds ago
- Depo-Provera and Actos drug interaction - 10 seconds ago
- Phenylephrine Hydrochloride and Hypoxic-Ischaemic Encephalopathy - 10 seconds ago
- Ticagrelor and Nebivolol Hydrochloride drug interaction - 15 seconds ago
- Moduretic 5-50 and Spinal Compression Fracture - 26 seconds ago
- Boniva and Osteosynthesis - 27 seconds ago
- Clorazepate Dipotassium and Alcohol Withdrawal Syndrome - 33 seconds ago